Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

被引:72
|
作者
Cartledge, JJ
Eardley, I
Morrison, JFB
机构
[1] St Jamess Univ Hosp, Pyrah Dept Urol, Leeds LS9 7TF, W Yorkshire, England
[2] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates
关键词
erectile dysfunction; diabetes mellitus; advanced glycation end-products (AGEs); aminoguanidine;
D O I
10.1046/j.1464-410x.2001.00067.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine if advanced glycation products (AGEs) are responsible for the lower neuronal and endothelial-derived nitric oxide (NO)mediated relaxation of corpus cavernosum in tissue in diabetic rats than in control rats. Materials and methods Diabetes was induced in male Wistar rats by an intraperitoneal injection with streptozotocin (60 mg/kg). One group of diabetic rats was given free access to water and standard diet. A second group was given standard diet and aminoguanidine with their water (50 mg/100 mL) from the initiation of diabetes. Two groups of rats that were not diabetic acted as age-matched controls. After 8 weeks animals were killed by cervical dislocation, corpus cavernosal tissue strips harvested and in an organ bath to measure isometric After 90 min of equilibration at optimal resting tension and contraction with 1 mu mol/L noradrenaline, the response to either acetylcholine or electrical field stimulation (EFS) after adding guanethidine (5 mu mol/L) and atropine (1 mu mol/L) was determined for each group. Results There was no difference between the baseline characteristics of all the experimental groups. After 8 weeks the mean body mass and glycosylated haemoglobin (HbA(1c)) were significantly greater in the diabetic than in control animals. Aminoguanidine had no effect on the recorded body mass or HbA(1c). The in vitro relaxation response to the application of acetylcholine or EFS of tissue strips from age-matched control animals fed a standard diet and those supplemented with aminoguanidine were the same. The administration of aminoguanidine to diabetic animals for 8 weeks reversed the expected impaired relaxation response to acetylcholine; the response to EFS was similar. Conclusion AGEs are more prevalent in erectile tissue from diabetic than in control animals. Aminoguanidine reversed the impairment in neuronal and endothelial NO-mediated penile smooth muscle relaxation seen in diabetes. As aminoguanidine prevents AGE formation, erectile dysfunction in diabetes is probably caused partly by the generation of AGEs.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 50 条
  • [1] Upregulation of aspartoacylase seen in diabetes is due to advanced glycation end-products
    Surendran, Sankar
    MEDICAL HYPOTHESES, 2007, 68 (04) : 926 - 926
  • [2] Advanced Glycation End-products Enhance Calcification in Vascular Smooth Muscle Cells
    Ren, X.
    Shao, H.
    Wei, Q.
    Sun, Z.
    Liu, N.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (03) : 847 - 854
  • [3] Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin
    Khan, MA
    Mumtaz, FH
    Mikhailidis, DP
    Morgan, RJ
    BJU INTERNATIONAL, 2000, 86 (06) : 756 - 757
  • [4] Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin
    Cartledge, JJ
    Eardley, I
    Morrison, JFB
    BJU INTERNATIONAL, 2000, 85 (06) : 735 - 741
  • [5] Advanced Glycation End-Products in Skeletal Muscle Aging
    Olson, Lucas C.
    Redden, James T.
    Schwartz, Zvi
    Cohen, David J.
    McClure, Michael J.
    BIOENGINEERING-BASEL, 2021, 8 (11):
  • [6] Advanced Glycation End-Products in Complications of Diabetes Mellitus
    Parmaksiz, Ilker
    MARMARA MEDICAL JOURNAL, 2011, 24 (03): : 141 - 148
  • [7] Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin - Reply
    Cartledge, J
    Eardley, I
    Morrison, JFB
    BJU INTERNATIONAL, 2000, 86 (06) : 757 - 757
  • [8] Lung cancer and diabetes: A role for advanced glycation end-products?
    Rigalleau, Vincent
    Foussard, Ninon
    Bertrand, Alexia
    Monlun, Marie
    Blanco, Laurence
    Mohammedi, Kamel
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (01)
  • [9] Dietetics advanced glycation end-products and chronic complications of diabetes
    Porto Barbosa, Junia Helena
    de Oliveira, Suzana Lima
    Tojal e Seara, Luci
    REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION, 2009, 22 (01): : 113 - 124
  • [10] Advanced glycation end-products: a review
    Singh, R
    Barden, A
    Mori, T
    Beilin, L
    DIABETOLOGIA, 2001, 44 (02) : 129 - 146